🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseGLP-1 hepatoprotection — looking for input Page 5

GLP-1 hepatoprotection — looking for input

emma_london Sat, Jan 3, 2026 at 5:22 PM 32 replies 1,569 viewsPage 5 of 7
mona_PHX
Member
189
890
Dec 2024
Phoenix, AZ
Jan 5, 2026 at 9:04 AM#21
labquiet_amy said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Careful with the causal language. Two things moving together in a period when five things changed is not a mechanism, and stating it as one makes the thread less useful to somebody reading it later.

34 7RetaRick_CA, JenPlateau, SallyK_inj and 31 others
Reply Quote Save Share Report
andrew_nyc
Member
534
2,345
Apr 2024
New York, NY
Jan 5, 2026 at 3:42 PM#22
labquiet_amy said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

No disagreement, though the timescale matters more than the mechanism here. Most of what looks like a difference in kind turns out to be a difference in how long somebody waited.

35 8Dr.NateNeph, PharmD_Rodriguez, julia.endo and 32 others
Reply Quote Save Share Report
denise_HTX
Member
145
678
Jan 2025
Houston, TX
Jan 5, 2026 at 10:20 PM#23
labquiet_amy said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

This is exactly what I could not find anywhere else. Printing the relevant bit and taking it with me.

36 9JessicaH_TX, KevinCompounds, TirzTom and 33 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
roxy_nash
Member
178
890
Dec 2024
Nashville, TN
Jan 6, 2026 at 4:58 AM#24

Clinical perspective, offered as context rather than as advice. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Ask again with the specifics and you will get a better answer than this one.

37 10Dr.NephBHM_UK, kim_atl_prep, sarah_TO and 34 others
Reply Quote Save Share Report
LeilaHI
Member
167
789
Jan 2025
Honolulu, HI
Jan 6, 2026 at 11:36 AM#25
roxy_nash said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

This is my experience too, for whatever a second data point is worth.

38 11amsterdam_pete, LondonLisa, mike_nyc and 35 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register